A. General Policy

1) Submitted articles or substantial parts of it should not have been previously published or be currently under consideration for publication elsewhere.

 

2) Conflicts of interest: Authors are required to acknowledge financial conflicts of interest or other interests that may influence the manuscript.

 

3) Ethical consent: Submission of a manuscript to the journal implies that all authors have read and agreed to its content, Research carried out on humans must include astatement confirming the informed consent was obtained from each subject or subject’s guardian and any experimental research on animals should be used after approval of the experimental protocol by a local ethics committee.

 

4) Copyright: Accepted manuscripts become the permanent property of the journal and may not be reproduced, in whole or in part, without the written permission of the editor.

 

5) Submission: Manuscripts should be submitted electronically to the following email address: fastmedicaljournal@gmail.com

 

B. Peer Review Process

Articles that are selected for peer review will be reviewed by two or more referees. Authors can suggest names of three expert reviewers, but selection remains a prerogative of the editor. The corresponding author is notified as soon as possible of the editor decision to accept, reject, or require modifications.

 

C. Manuscript Formatting Guidelines

1) Manuscripts submitted in English and must be type written in double-spaced with margins of at least 2.5 cm all around the paper and a font size of 12 with Times New Roman. The text should be in single-column format.

 

2) This order should follow: Title, Authors, Affiliations, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion (The Results and discussion may be combined into a single section or presented separately), Conclusions, Acknowledgements, References, Figures with Figure Captions, Tables and Table Captions, Supplementary Data (if any).

 

3) The title page should bear the title of the paper, complete names and affiliation of all authors, including contact details of corresponding author (Telephone, Fax and E-mail address). An abbreviated title (not more than 50 letters and spaces) for use as a running headline should also be supplied.

 

4) The abstract should summarize the manuscript content in 250-300 words or less. Following the abstract should be included a list of keywords (3-5).

 

5) All Tables, Figures, Drawings and Graphs should be provided in separate pages and numbered according to their sequence in the text. The tables captions should be placed above and other captions should be placed below.

 

6) All publications cited in the text should be presented in a list of references following the text of the manuscript. In the text refer to references by a number in parentheses, and the full reference should be formatted according to standard reference style such as Vancouver reference system.

 

Examples of formatting are shown below (endnote style).

Journal

Authors (if the number of authors exceed 6, the phrase "et al." should be used for any additional authors). Title of article. Title of Journal, abbreviated. Date of publication; Volume (Issue): Page numbers.

Hashemi M, Parhiz H, Hatefi A, Ramezani M. Modified polyethylenimine with histidine-lysine short peptides as gene carrier. Cancer Gene Ther. 2010; 18: 9-12.

 

Book

Authors. Title of book. Edition. Place of publication: Publisher; Year of publication.

Badea I, Foldvari M. Gemini surfactant-based gene therapy: non-invasive gene delivery. Germany: LAP LAMBERT Academic Publishing; 2012. 

Authors. Title of chapter. In: Editors, editors. Title of book. Edition. Place of publication: Publisher; Year of publication. Page numbers.

Xiong XB, Lavasanifar A. Amphiphilic block copolymer based nanocarriers for drug and gene delivery. In: Ales Prokop, edithor. Intracellular delivery, fundamentals and applications. Netherlands: Springer; 2011. p. 251-289.

 

Patent

Authors. Title. Patent number, Year of publication.

Farokhzad OC, Jon SY, Langer RS. Controlled release nanoparticle having bound oligonucleotide for targeted delivery. US patent No. 7727969, 2010.

 

Web page

Title of web page [Medium]. Place of publication: Publisher; Date of publication [updated Year Month Day; cited Year Month Day]. Available from: URL

Cancer-Pain.org [Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org

 

Online Sources

References to online sources include articles in press.

Authors. Title of article. Title of Journal, abbreviated. Date of publication. Volume (Issue): Page numbers. Available from: URL

Keeney M, Lai JH, Yang F. Recent progress in cartilage tissue engineering. Curr Opin Biotechnol. 2011. Available from URL: http://www.ncbi.nlm.nih.gov/pubmed/21531126 (DOI: 10.1016/j.copbio.2011.04.003)

 

Thesis

Author. Title of thesis. Degree. Place of publication: University; Year of publication.

Parhiz H. Preparation and evaluation of transfection efficiency of nanoparticles of Polyethyleneimine (PEI) coated with arginine rich sequences as non-viral vectors used in gene therapy. PhD Thesis. Mashhad: Mashhad University of Medical Sciences; 2011.

 

Page charge

This journal has a fixed 170 $ charge per each article.